FILTERED RESULTS
FILTERS
•
·
·
FILTERED RESULTS
U.S. House Democrat Proposes Bill to Ban Candidate Trades in Prediction Markets
Gold Steadies as Dollar Strengthens on European Debt Risks
Modern Treasury Seeks Approval to Establish National Trust Bank
After notching two jet fighter contracts, Boeing could be turning the page
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.18%
Binance Launches AI Product Suite to Enhance User Experience
Federal Reserve Board announces approval of application by Isabella Bank Corporation
PTC Rises on Schneider Electric’s $23.7 Billion Takeover Deal | Closing Bell
Goldman Sachs names top utility stocks ahead of earnings season
McDonald’s hit with class action alleging AI-powered menu price-fixing
McKesson and CD&R near $5bn-plus deal to buy infusion services provider
Lucid’s Cost-Cut Plan Leads to Pullback in Quarterly EV Output
Lucid’s third-quarter deliveries miss estimates as it cuts output to run down inventory
Wall Street ends within sight of record close as traders brush off bond rout
Nasdaq notches record high close as investors focus on earnings
SpaceX Stock Rises Significantly, Reestablishing Musk's Trillionaire Status
China's Markets to Reopen After Holiday on October 8
Lucid Motors Reports 6.7% Decline in Q3 Deliveries Amid Production Cuts
Virgin Media Bonds Sink to Record Low as Broadband Deal in Doubt
Oprah-Backed True Food Kitchen Files Bankruptcy After Expansion
Yemeni government forces drive Houthis from Bab el-Mandeb Strait
Fitch affirms Barbados at ’B+’ with positive outlook as fiscal metrics improve
Moody’s revises BWX Technologies outlook to positive on strong naval posture
Why is Telos stock rallying today?
Top power technology stocks for selective trading, says Oppenheimer
Copper Advances as Tech Rally Outweighs Surging Bond Yields
Sarah Jessica Parker, Astrea London Bet Big on Lab Grown Gemstones
Banks Kick Off €4.7 Billion Debt Sale for Bain’s Volkswagen Deal
When a label costs you $4bn in market cap
U.S. Treasury Yields Reach Highest Levels in 24 Years
Crude Oil WTI tests 50% Fib at $88.76 amid downtrend: Live
Silver consolidates near $61.54 with bear flag 80% complete: Live
Alphabet C wedged near $350 resistance: Live levels
Nasdaq 100 tests all-time high at 31,336: Live levels
USD/CHF Currency Pair Shows Signs of Recovery Amid Technical Resistance
Municipal Borrowers Postpone $6 Billion in Refinancing Amid High Yields
US closes 2024 privacy review into US airlines without seeking penalties
Euro drops to 17-month low on France debt concerns
New York Declares State of Emergency Over Measles Outbreak
SpaceX Proposes 32-Mile Natural Gas Pipeline in Florida for Starship Launches
Cargill’s Earnings Slump 52% With High Cattle Costs, Cocoa Loss
Oil slips in choppy trade amid Yemen offensive, recovering exports, and G7 move
Factbox-Top cases on the US Supreme Court’s docket
Genmab stock surges 11% on positive cancer drug trial data
U.S. Pressure Campaign Impacting Iran's Economy, Says Treasury Secretary
Reflection AI boosts US ambition to compete with Chinese ‘open’ models
Wikipedia Operator Links OpenAI's Rogue Agents to May Data Service Disruption
Northwest European gasoline margins hold steady at $40.60
Chevron elevates CFO to lead oil and gas operations
Nasdaq hits record high as investors focus on earnings
IMF research shows better tax system design can raise revenue, growth without higher rates
Dollar Extends Relentless Rally Even as Cracks Start to Emerge
SpaceX Plans to Construct Gas Pipeline in Florida
High Yields Force Muni Bond Borrowers to Delay Refinancing Deals
S&P 500 Closes In on Record High as Tech Rallies: Markets Wrap
Meta and Microsoft Reduce Dependency on Anthropic's Claude
Tories pledge big tax cuts in push to win over wealthy voters
Roundhill Launches S&P 500 Target 10,000 ETF
'Spaghetti Cannon' Of ETFs: Corgi's Weniger
Saudi Arabia, Pakistan, and Turkey Form Military Alliance for Rapid Deployment
CFTC proposes federal framework for crypto exchanges
Why is Emergent Biosolutions stock surging today?
Analysis-After notching two Naval jet fighter contracts, Boeing could be turning the page
Nashville Symphony Receives $10 Million Lifeline From Oracle
3X Commodity ETFs: 'SEC Giving Market What It Wants'
How Invesco Fights Off 'QQQ' Competition
Cocoa Prices Rise Amid El Niño Threat to West African Supplies
Petronas CEO Warns of LNG ‘Bloodbath’ Risks as Prices Surge
Troubled Caribbean Refinery Eyes Restart Amid Global Fuel Crunch
AstraZeneca CEO Highlights Potential of Summit Drug in Cancer Treatment
Pascal Soriot, CEO of AstraZeneca, announced that the company's new drug, Summit, could pave the way for the next generation of cancer treatment combinations. This statement was made during an exclusive interview with CNBC at the site of AstraZeneca's recently inaugurated $1 billion research and development facility located in Kendall Square, Cambridge, Massachusetts.
Soriot emphasized the significance of the $2 billion investment in the Summit drug, which aims to enhance the effectiveness of existing cancer therapies. He expressed optimism about the potential of this drug to transform treatment protocols and improve patient outcomes in oncology.
The establishment of the R&D facility in Cambridge is part of AstraZeneca's broader strategy to advance its research capabilities and foster innovation in drug development. This investment underscores the company's commitment to addressing critical healthcare challenges globally.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News